What is the CyPass Micro-Stent?
The CyPass Micro-Stent is intended to be implanted during cataract surgery and used to treat mild to moderate primary open-angle glaucoma, according to Medagadget. The device is marketed by Alcon, a division of Novartis which acquired Transcend Medical, the original developer of the technology, in February 2016. The stent creates a channel for liquids to flow out from the anterior chamber of the eye, which reduces the intraocular pressure.
How Does it Work?
The micro-stent is designed to rest in the supraciliary space between the sclera and the ciliary body. The device is shaped like a cylinder that has an entry port on one end and a series of holes throughout which diffuse the flowing liquid.
Alcon CyPass Recall
Citing “uncompromising commitment to patient safety,” Alcon on Sept. 14, 2018, announced a recall for all versions of the CyPass micro-stent from the global market, and advised surgeons to immediately cease further implantation of the device. The company’s decision was based on safety data from the COMPASS-XT study, which found a statistically significant difference in endothelial cell loss at 5 years after surgery in patients who were implanted with the Alcon stent in cataract surgery compared to those who underwent cataract surgery alone.
“This notice is to alert eye care providers and patients of the risk of eye damage in people who have the device implanted,” FDA said in the recall notice. “Based on information from a post-approval study required by the FDA, Alcon (the manufacturer) is collecting all unused devices (voluntary market withdrawal) and is asking physicians to stop implanting the device.”
Potential complications of a defective CyPass Micro-Stent may include:
- Severe eye damage
- Long-term endothelial cell loss
- Cornea damage
- Vision loss
- Swelling of the eye
- Cloudy vision
- Eye pain
- Stent removal surgery
- Corneal transplant
About Class Action Lawsuits
Although we are a nationally recognized class action firm, the Medical Device Litigation Group at our law firm has decided against the filing of an Alcon CyPass Recall Class Action Suit and is currently filing individual claims on behalf of injured people and/or their family members that have suffered eye damage after cataract surgery with the CyPass Micro-Stent.
A class action is a type of lawsuit filed with the court on behalf of large group of people or “class” of individuals that have been injured or wronged. The class is represented by the law firm and the case is generally decided upon a single member of the class who is sometimes referred to as the “class representative or class rep.”
Why Our Law Firm Is Filing Individual Lawsuits Opposed To a Class Action
In some instances, a class action may offer some advantages, as they aggregate a large number of individualized claims into one representational lawsuit. The aggregation can increase the efficiency of the legal process, lower the costs of litigation and in some cases offer the solution to a common problem wherein small recoveries do not provide the incentive for any individual or law firm to file an individual lawsuit.
However, a class action suit can also be a detriment to many class members, as they are often forced into a blanket “low ball settlement” and higher attorney fees. At Schmidt & Clark, LLP we understand that our clients are suffering emotionally and economically due to loss of wages and/or high medical bills and we plan to maximize each client’s recovery by filing individual lawsuits on their behalf.
Do I Have an Alcon CyPass Recall Class Action Lawsuit?
The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Alcon Cypass Recall Lawsuits. We are handling individual litigation nationwide and currently accepting new stent eye damage cases in all 50 states.
Free Case Evaluation: Again, if you had eye damage after undergoing cataract surgery with the Alcon CyPass microstent, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and we can help.